Literature DB >> 3021463

C-reactive protein in the differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsillitis in children.

A Putto, O Meurman, O Ruuskanen.   

Abstract

Sixty-two children with febrile exudative tonsillitis were studied to explore whether quantitative measurements of serum C-reactive protein (CRP) are useful in differentiating viral from streptococcal tonsillitis. There were 23 cases of adenoviral tonsillitis, 21 of EB viral tonsillitis and 18 of streptococcal tonsillitis. Measurements of CRP, WBC counts and erythrocyte sedimentation rates (ESR) were not useful in distinguishing viral from streptococcal tonsillitis. Seventy-four percent of patients with adenoviral tonsillitis were under the age of 3 years and 71% of the patients with Epstein-Barr (EB) viral tonsillitis were under the age of 6 years whereas 72% of the patients with streptococcal tonsillitis were over the age of 6 years. Age was clearly the most important factor in distinguishing between viral and bacterial tonsillitis in children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021463     DOI: 10.1007/bf00446066

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  The significance of the C-reactive protein estimation in streptococcal and allied disease.

Authors:  S F DAWSON
Journal:  Arch Dis Child       Date:  1957-10       Impact factor: 3.791

2.  C-reactive protein in respiratory virus infections.

Authors:  O Ruuskanen; A Putto; H Sarkkinen; O Meurman; K Irjala
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

3.  Nitroblue tetrazolium dye reduction by neutrophils from patients with streptococcal pharyngitis.

Authors:  R M Shapera; J M Matsen
Journal:  Pediatrics       Date:  1973-02       Impact factor: 7.124

4.  Observations on childhood infections with the Epstein-Barr virus.

Authors:  G Henle; W Henle
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

5.  Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis.

Authors:  W P Glezen; W A Clyde; R J Senior; C I Sheaffer; F W Denny
Journal:  JAMA       Date:  1967-11-06       Impact factor: 56.272

6.  Failure to isolate streptococci from children under the age of 3 years with exudative tonsillitis.

Authors:  J J Alpert; M R Pickering; R J Warren
Journal:  Pediatrics       Date:  1966-10       Impact factor: 7.124

7.  C-reactive protein in streptococcal pharyngitis.

Authors:  E L Kaplan; L W Wannamaker
Journal:  Pediatrics       Date:  1977-07       Impact factor: 7.124

8.  Quantitative C-reactive protein (CRP) determined by an immunoturbidimetric method in rapid differential diagnosis of acute bacterial and viral diseases of children.

Authors:  H Peltola; M L Laipio; M A Siimes
Journal:  Acta Paediatr Scand       Date:  1984-03

9.  Rapid diagnosis of adenoviral tonsillitis: a prospective clinical study.

Authors:  O Ruuskanen; H Sarkkinen; O Meurman; P Hurme; T Rossi; P Halonen; P Hänninen
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

10.  Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy.

Authors:  M S Krober; J W Bass; G N Michels
Journal:  JAMA       Date:  1985-03-01       Impact factor: 56.272

View more
  10 in total

1.  Immunochromatography test for rapid diagnosis of adenovirus respiratory tract infections: comparison with virus isolation in tissue culture.

Authors:  H Tsutsumi; K Ouchi; M Ohsaki; T Yamanaka; Y Kuniya; Y Takeuchi; C Nakai; H Meguro; S Chiba
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Pediatric Respiratory Virus Infections During the COVID-19 Pandemic in a Region Without Active Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Circulation.

Authors:  Sosuke Kakee; Yoichi Mino; Keisuke Okuno; Daisuke Kawaba; Atsushi Maejima; Noriyuki Namba
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

3.  Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis.

Authors:  Soner Sertan Kara; Ozcan Erel; Tugba Bedir Demirdag; Burcu Ceylan Cura Yayla; Belgin Gulhan; Salim Neselioglu; Meltem Polat; Gokhan Kalkan; Anil Tapisiz; Hasan Tezer
Journal:  Redox Rep       Date:  2016-04-20       Impact factor: 4.412

4.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

5.  Tonsillitis in children: unnecessary laboratory studies and antibiotic use.

Authors:  Antti Kunnamo; Matti Korppi; Merja Helminen
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

6.  Serum Inflammatory Markers in Patients with Adenovirus Respiratory Infection.

Authors:  Junping Sun; Yongjiu Xiao; Mingyue Zhang; Ting Ao; Shan Lang; Jianxin Wang
Journal:  Med Sci Monit       Date:  2018-06-07

7.  Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection.

Authors:  Lauri Ivaska; Jussi Niemelä; Johanna Lempainen; Riikka Österback; Matti Waris; Tytti Vuorinen; Jukka Hytönen; Kaisu Rantakokko-Jalava; Ville Peltola
Journal:  J Infect       Date:  2017-01-07       Impact factor: 6.072

8.  Hematological and biochemical factors predicting SARS fatality in Taiwan.

Authors:  Hsiao-Ling Chang; Kow-Tong Chen; Shu-Kuan Lai; Hung-Wei Kuo; Ih-Jen Su; Ruey S Lin; Fung-Chang Sung
Journal:  J Formos Med Assoc       Date:  2006-06       Impact factor: 3.282

Review 9.  Pharyngotonsillitis.

Authors:  Anna Stjernquist-Desatnik; Arne Orrling
Journal:  Periodontol 2000       Date:  2009-02       Impact factor: 7.589

10.  Immunochromatographic test for detection of adenovirus from respiratory samples: is it a real solution for pediatric emergency department?

Authors:  María Pilar Romero-Gómez; Rosario López López; Remedios González Montes; Cristina Ots Ruiz; Sara Hierro Cuesta; María Antonia Martín Crespo; Santos García García
Journal:  J Virol Methods       Date:  2013-10-03       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.